000 01837 a2200529 4500
005 20250516072657.0
264 0 _c20120612
008 201206s 0 0 eng d
022 _a1523-5866
024 7 _a10.1093/neuonc/nor219
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aRedaelli, Marco
245 0 0 _aHerpes simplex virus type 1 thymidine kinase-armed bovine herpesvirus type 4-based vector displays enhanced oncolytic properties in immunocompetent orthotopic syngenic mouse and rat glioma models.
_h[electronic resource]
260 _bNeuro-oncology
_cMar 2012
300 _a288-301 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650 0 4 _aAnimals
650 0 4 _aAntiviral Agents
_xtherapeutic use
650 0 4 _aBrain Neoplasms
_xtherapy
650 0 4 _aCattle
650 0 4 _aDisease Models, Animal
650 0 4 _aGanciclovir
_xtherapeutic use
650 0 4 _aGenetic Therapy
650 0 4 _aGenetic Vectors
650 0 4 _aGlioma
_xtherapy
650 0 4 _aHerpesvirus 1, Human
_xgenetics
650 0 4 _aHerpesvirus 4, Bovine
_xgenetics
650 0 4 _aHumans
650 0 4 _aImmunocompetence
650 0 4 _aMice
650 0 4 _aMice, Inbred C57BL
650 0 4 _aOncolytic Viruses
_xgenetics
650 0 4 _aProdrugs
_xtherapeutic use
650 0 4 _aRats
650 0 4 _aRats, Inbred F344
650 0 4 _aThymidine Kinase
_xgenetics
650 0 4 _aTumor Cells, Cultured
700 1 _aFranceschi, Valentina
700 1 _aCapocefalo, Antonio
700 1 _aD'Avella, Domenico
700 1 _aDenaro, Luca
700 1 _aCavirani, Sandro
700 1 _aMucignat-Caretta, Carla
700 1 _aDonofrio, Gaetano
773 0 _tNeuro-oncology
_gvol. 14
_gno. 3
_gp. 288-301
856 4 0 _uhttps://doi.org/10.1093/neuonc/nor219
_zAvailable from publisher's website
999 _c21446037
_d21446037